Showing results (111-120 of 1,827) with videos related to
Sort By:
Pageof 183
ESMO Open|November 7, 2024
Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare dataJ A Ajani, L Leung, S Kanters, et al.ESMO Open|November 14, 2024
PD-L1 thresholds predict efficacy of immune checkpoint inhibition in first-line treatment of advanced gastroesophageal adenocarcinoma. A systematic review and meta-analysis of seven phase III randomized trialsV Formica, C Morelli, L Fornaro, et al.ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.ESMO Open|October 5, 2024
Systemic treatments in recurrent or metastatic salivary gland cancer: a systematic reviewD Prost, S Iseas, M Gatineau, et al.ESMO Open|October 5, 2024
MRI-based radiomics for stratifying recurrence risk of early-onset rectal cancer: a multicenter studyP-Y Xie, Z-M Zeng, Z-H Li, et al.ESMO Open|October 12, 2024
Fruquintinib in refractory metastatic colorectal cancer: a multicenter real-world studyD Xu, S Zeng, W Qiu, et al.ESMO Open|October 19, 2024
Recursive partitioning analysis model for de novo metastatic nasopharyngeal carcinoma treated with locoregional radiotherapy following chemoimmunotherapyD Wen, L Gu, H Long, et al.ESMO Open|October 19, 2024
Global trends in adolescent and young adult female cancer burden, 1990-2021: insights from the Global Burden of Disease studyZ Huang, J Wang, H Liu, et al.ESMO Open|October 2, 2024
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational studyF Tosi, L Salvatore, E Tamburini, et al.ESMO Open|October 31, 2024
Safety of solid oncology drugs in older patients: a narrative reviewA Rousseau, A Géraud, R Geiss, et al.Pageof 183